New Pharmacology for Weight Loss with Dr. Gurdeep Singh


Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on September 16, 2022 20:54 (19d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 314685220 series 2613159
Tekijältä BMJ Group. Player FM:n ja yhteisömme löytämä — tekijänoikeuksien omistajana on kustantaja eikä Player FM ja ääntä lähetetään suoraan heidän palvelimiltaan. Napsauta Tilaa -painiketta, kun haluat seurata Player FM:n päivityksiä tai liittää syötteen URL-osoitteen muihin podcast-sovelluksiin.
In this episode of the JIM podcast, Editor-in-Chief Dr. Richard McCallum speaks with Dr. Gurdeep Singh, the first author of the review entitled “Wegovy(Semaglutide) a new weight loss drug for chronic weight management” which was Editor’s choice in the upcoming January issue of the Journal of Investigative Medicine.

Dr. Gurdeep Singh, MD, FACE a Clinical Endocrinologist from Lake Erie College of Osteopathic Medicine at Our Lady of Lourdes Memorial Hospital in Binghamton, New York.

32 jaksoa